XM does not provide services to residents of the United States of America.

Pot stocks dive as Florida rejects legalization of recreational marijuana



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Pot stocks dive as Florida rejects legalization of recreational marijuana</title></head><body>

Updates shares, recasts

Nov 6 (Reuters) -Shares of pot companies slid on Wednesday after a ballot measure to legalize the recreational use of marijuana in Florida failed to get the required majority to pass, even as the firms invested millions in a campaign to tap the lucrative market.

Toronto-listed shares of Canopy Growth WEED.TO and Trulieve Cannabis TRUL.CD tumbled 20.4% and 44.2%, respectively.

Tilray Brands' TLRY.O shares declined more than 11%, while the U.S.-listed shares of SNDL SNDL.O and Cronos Group CRON.O fell 13.8% and 7.2%, respectively.

ETF AdvisorShares Pure US Cannabis MSOS.P plunged 24.1%.

Florida was touted as a very attractive market. An estimate from cannabis analytics company Headset had indicated $4.9 billion to $6.1 billion in adult-use sales during the first year of implementation.

The passage of Amendment 3 would have legalized the sale of marijuana for recreational use to adults 21 years of age and older from medical marijuana treatment centers and other state-licensed entities.

The initiative received more than 55% of the votes in favor but fell short of the 60% majority needed to pass.

Twenty-four U.S. states have so far legalized the recreational use of cannabis, though it continues to be illegal at the federal level.

In 2016, Florida voters passed a constitutional amendment allowing medical marijuana in the state.

Major pot firms had made substantial contributions to Smart & Safe Florida, the group advocating for the passage of Amendment 3.

The focus now shifts to efforts to reclassify marijuana use as a less serious federal offence. President-elect Donald Trump has also publicly supported marijuana reforms and legislations in the months leading up to the election.

ATB Capital Markets analyst Frederico Gomes said if marijuana use is reclassified as a less serious federal crime, it could more than offset any effects of the failure to pass the amendment.



Reporting by Mrinalika Roy and Sourasis Bose in Bengaluru; Editing by Abinaya Vijayaraghavan and Sriraj Kalluvila

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.